These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1770635)

  • 1. [Effect of protease inhibitor on primary glomerulonephritis and the mechanism of the effect].
    Onbe T; Makino H; Haramoto T; Wada J; Ogura T; Kumagai I; Murakami K; Fukushima M; Ota Z
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):753-9. PubMed ID: 1770635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of camostat mesilate on heavy proteinuria in various nephropathies.
    Matsubara M; Taguma Y; Kurosawa K; Hotta O; Suzuki K; Futaki G
    Clin Nephrol; 1989 Sep; 32(3):119-23. PubMed ID: 2791362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of camostat mesilate for the treatment of advanced diabetic nephropathy.
    Matsubara M; Taguma Y; Kurosawa K; Hotta O; Suzuki K; Ishizaki M
    J Lab Clin Med; 1990 Aug; 116(2):206-10. PubMed ID: 2394938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics.
    Matsubara M; Taguma Y; Saito T; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):411-6. PubMed ID: 1635286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of proteinase inhibitor camostat mesilate on nephrotic syndrome with diabetic nephropathy.
    Onbe T; Makino H; Kumagai I; Haramoto T; Murakami K; Ota Z
    J Diabet Complications; 1991; 5(2-3):167-8. PubMed ID: 1770033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral camostat mesilate on hematuria and/or proteinuria in children.
    Asami T; Tomisawa S; Uchiyama M
    Pediatr Nephrol; 2004 Mar; 19(3):313-6. PubMed ID: 14740285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of camostat mesilate on persistent proteinuria of IgA nephropathy.
    Matsubara M; Taguma Y; Saito T; Yoshinaga K
    Nephron; 1992; 60(2):244-5. PubMed ID: 1553016
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of camostat mesilate on urinary protein excretion in three patients with advanced diabetic nephropathy.
    Ikeda Y; Ito H; Hashimoto K
    J Diabetes Complications; 1999; 13(1):56-8. PubMed ID: 10232711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of FUT-175 on complement activation and its application for glomerulonephritis with hypocomplementemia.
    Fujita Y; Inoue I; Inagi R; Miyata T; Shinzato T; Sugiyama S; Miyama A; Maeda K
    Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):393-7. PubMed ID: 8341019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory chronic urticaria treated effectively with the protease inhibitors, nafamostat mesilate and camostat mesilate.
    Takahagi S; Shindo H; Watanabe M; Kameyoshi Y; Hide M
    Acta Derm Venereol; 2010 Jul; 90(4):425-6. PubMed ID: 20574618
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of camostat mesilate on puromycin aminonucleoside nephrotic rats.
    Suzuki J; Suzuki S; Nozawa R; Kumaki S; Kume K; Higuchi E; Kamiyama S; Ohara N; Yugeta E; Kato K
    Fukushima J Med Sci; 1988 Jun; 34(1):21-5. PubMed ID: 3254858
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical effect of dipyridamole in patients with IgA nephropathy.
    Yagame M; Tomino Y; Miura M; Suga T; Endoh M; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1986 Nov; 11(5):329-33. PubMed ID: 2960035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases.
    Tencer J; Torffvit O; Björnsson S; Thysell H; Grubb A; Rippe B
    Clin Nephrol; 1997 Oct; 48(4):212-9. PubMed ID: 9352154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents.
    Ishikura H; Nishimura S; Matsunami M; Tsujiuchi T; Ishiki T; Sekiguchi F; Naruse M; Nakatani T; Kamanaka Y; Kawabata A
    Life Sci; 2007 May; 80(21):1999-2004. PubMed ID: 17433371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta.
    Okuno M; Akita K; Moriwaki H; Kawada N; Ikeda K; Kaneda K; Suzuki Y; Kojima S
    Gastroenterology; 2001 Jun; 120(7):1784-800. PubMed ID: 11375959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
    Freise J; Melzer P; Schmidt FW; Horbach L
    Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effects of camostat mesilate on plasma kallikrein, plasma kininase II and renal kallikrein of man.
    Bönner G; Babst H; Kaufmann W
    Arzneimittelforschung; 1987 May; 37(5):535-7. PubMed ID: 3040018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective?
    Ashizawa N; Hashimoto T; Miyake T; Shizuku T; Imaoka T; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Apr; 21(4):767-71. PubMed ID: 16677167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.